Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Gross Margin 2010-2025 | AMRX

Current and historical gross margin for AMNEAL PHARMACEUTICALS, INC (AMRX) over the last 10 years. The current gross profit margin for AMNEAL PHARMACEUTICALS, INC as of March 31, 2025 is %.
  
AMNEAL PHARMACEUTICALS, INC Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $2.83B $1.04B 36.71%
2024-12-31 $2.79B $1.02B 36.54%
2024-09-30 $2.68B $0.95B 35.37%
2024-06-30 $2.60B $0.91B 35.07%
2024-03-31 $2.50B $0.88B 35.31%
2023-12-31 $2.39B $0.82B 34.29%
2023-09-30 $2.39B $0.85B 35.44%
2023-06-30 $2.31B $0.81B 34.89%
2023-03-31 $2.27B $0.79B 34.67%
2022-12-31 $2.21B $0.79B 35.47%
2022-09-30 $2.14B $0.74B 34.39%
2022-06-30 $2.12B $0.74B 34.90%
2022-03-31 $2.10B $0.75B 35.83%
2021-12-31 $2.09B $0.77B 36.72%
2021-09-30 $2.07B $0.77B 37.25%
2021-06-30 $2.06B $0.71B 34.27%
2021-03-31 $1.99B $0.64B 32.06%
2020-12-31 $1.99B $0.63B 31.51%
2020-09-30 $1.88B $0.57B 30.37%
2020-06-30 $1.74B $0.49B 28.23%
2020-03-31 $1.68B $0.45B 26.92%
2019-12-31 $1.63B $0.35B 21.65%
2019-09-30 $1.73B $0.44B 25.19%
2019-06-30 $1.83B $0.58B 31.84%
2019-03-31 $1.83B $0.65B 35.66%
2018-12-31 $1.66B $0.72B 43.05%
2018-09-30 $1.50B $0.77B 51.07%
2018-06-30 $1.28B $0.70B 54.81%
2018-03-31 $1.13B $0.65B 57.51%
2017-12-31 $1.03B $0.53B 50.97%
2017-09-30 $1.09B $0.87B 79.84%
2017-06-30 $1.06B $0.57B 53.67%
2017-03-31 $0.98B $0.52B 53.22%
2016-12-31 $1.02B $0.60B 58.68%
2016-09-30 $0.91B $0.13B 13.86%
2016-06-30 $0.90B $0.39B 42.68%
2016-03-31 $0.94B $0.40B 42.10%
2015-12-31 $0.86B $0.35B 41.05%
2015-09-30 $0.71B $0.30B 42.17%
2015-06-30 $0.65B $0.29B 44.74%
2015-03-31 $0.62B $0.31B 50.65%
2014-12-31 $0.60B $0.31B 52.52%
2014-09-30 $0.57B $0.29B 50.53%
2014-06-30 $0.54B $0.25B 46.21%
2014-03-31 $0.48B $0.20B 41.20%
2013-12-31 $0.51B $0.20B 38.87%
2013-09-30 $0.55B $0.23B 41.49%
2013-06-30 $0.57B $0.26B 45.84%
2013-03-31 $0.60B $0.28B 46.26%
2012-12-31 $0.58B $0.28B 48.63%
2012-09-30 $0.60B $0.30B 49.33%
2012-06-30 $0.57B $0.28B 48.95%
2012-03-31 $0.53B $0.26B 49.25%
2011-12-31 $0.51B $0.26B 50.39%
2011-09-30 $0.45B $0.23B 51.10%
2011-06-30 $0.64B $0.33B 51.72%
2011-03-31 $0.67B $0.35B 53.23%
2010-12-31 $0.88B $0.54B 61.32%
2010-09-30 $0.96B $0.58B 60.25%
2010-06-30 $0.72B $0.45B 63.04%
2010-03-31 $0.62B $0.40B 64.15%
2009-12-31 $0.36B $0.19B 52.51%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.589B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.33
Zoetis (ZTS) United States $67.467B 25.17
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $44.157B 22.63
BeOne Medicines - (ONC) Cayman Islands $30.596B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.886B 0.00
Summit Therapeutics (SMMT) United States $20.995B 0.00
Merck (MKKGY) Germany $16.698B 12.23
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.449B 11.90
Neurocrine Biosciences (NBIX) United States $13.210B 45.25
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.239B 0.00
Stevanato Group S.p.A (STVN) Italy $7.732B 47.28
Corcept Therapeutics (CORT) United States $7.725B 62.80
Madrigal Pharmaceuticals (MDGL) United States $7.659B 0.00
Grifols, S.A (GRFS) Spain $6.937B 0.00
Ionis Pharmaceuticals (IONS) United States $6.807B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.310B 0.00
Hypermarcas (HYPMY) Brazil $3.178B 20.91
Crinetics Pharmaceuticals (CRNX) United States $2.987B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.583B 9.05
NewAmsterdam Pharma (NAMS) Netherlands $2.349B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.090B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.797B 0.00
Ocular Therapeutix (OCUL) United States $1.792B 0.00
ARS Pharmaceuticals (SPRY) United States $1.755B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.315B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.196B 23.92
Ardelyx (ARDX) United States $1.101B 0.00
ProKidney (PROK) United States $1.092B 0.00
Dyne Therapeutics (DYN) United States $1.061B 0.00
Enliven Therapeutics (ELVN) United States $1.053B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.024B 0.00
Collegium Pharmaceutical (COLL) United States $1.021B 5.51
Verve Therapeutics (VERV) United States $0.982B 0.00
Xeris Biopharma Holdings (XERS) United States $0.823B 0.00
KalVista Pharmaceuticals (KALV) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.751B 0.00
Zevra Therapeutics (ZVRA) United States $0.674B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.624B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.583B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Organogenesis (ORGO) United States $0.566B 0.00
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Bioventus (BVS) United States $0.545B 13.83
Siga Technologies (SIGA) United States $0.484B 10.12
Tourmaline Bio (TRML) United States $0.476B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.399B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.345B 9.31
Altimmune (ALT) United States $0.339B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.308B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Nektar Therapeutics (NKTR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.78
Nanobiotix S.A (NBTX) France $0.246B 0.00
OmniAb (OABI) United States $0.242B 0.00
Esperion Therapeutics (ESPR) United States $0.222B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.197B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.171B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Liminatus Pharma (LIMN) United States $0.140B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Korro Bio (KRRO) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Jupiter Neurosciences (JUNS) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 43.11
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.57
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00